Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析

◆英語タイトル:Cleveland BioLabs Inc (CBLI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH63148FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cleveland BioLabs Inc (Cleveland) is a bio pharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of toll-like receptor that finds application in radiation mitigation, oncology immunotherapy, and vaccines. It also provides entolimod-oncology, CBLB612, SA-702 – vaccine adjuvant, mobilan, and CBL0137. Cleveland’s clinical-stage drug candidates are used for the treatment of cancer and protection from lethal radiation. The company’s products are developed using protectan technology and curaxin technology. It partners with the clinic, cancer institute, and others. The company operates in the US and Russia. Cleveland is headquartered in Buffalo, New York, the US.

Cleveland BioLabs Inc Key Recent Developments

Feb 17,2021: 16:15 ET Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc. Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company developing novel approaches to activate the immune system, file
May 15,2020: Cleveland BioLabs reports first quarter 2020 financial results and development progress

This comprehensive SWOT profile of Cleveland BioLabs Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cleveland BioLabs Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cleveland BioLabs Inc – Key Information
Cleveland BioLabs Inc – Overview
Cleveland BioLabs Inc – Key Employees
Cleveland BioLabs Inc – Key Employee Biographies
Cleveland BioLabs Inc – Key Operational Heads
Cleveland BioLabs Inc – Major Products and Services
Cleveland BioLabs Inc – History
Cleveland BioLabs Inc – Company Statement
Cleveland BioLabs Inc – Locations And Subsidiaries
Cleveland BioLabs Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cleveland BioLabs Inc – Business Description
Cleveland BioLabs Inc – Corporate Strategy
Cleveland BioLabs Inc – SWOT Analysis
SWOT Analysis – Overview
Cleveland BioLabs Inc – Strengths
Cleveland BioLabs Inc – Weaknesses
Cleveland BioLabs Inc – Opportunities
Cleveland BioLabs Inc – Threats
Cleveland BioLabs Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cleveland BioLabs Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cleveland BioLabs Inc, Key Information
Cleveland BioLabs Inc, Key Ratios
Cleveland BioLabs Inc, Share Data
Cleveland BioLabs Inc, Major Products and Services
Cleveland BioLabs Inc, History
Cleveland BioLabs Inc, Key Employees
Cleveland BioLabs Inc, Key Employee Biographies
Cleveland BioLabs Inc, Key Operational Heads
Cleveland BioLabs Inc, Other Locations
Cleveland BioLabs Inc, Subsidiaries
Cleveland BioLabs Inc, Key Competitors
Cleveland BioLabs Inc, SWOT Analysis
Cleveland BioLabs Inc, Ratios based on current share price
Cleveland BioLabs Inc, Annual Ratios
Cleveland BioLabs Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • HealthEquity Inc (HQY):企業の財務・戦略的SWOT分析
    Summary HealthEquity Inc (HealthEquity) is a healthcare service provider that offers health savings management services. The company provides integrated health accounts such as health savings account, health reimbursement arrangements, flexible spending accounts for health plans, insurance companies …
  • Territorial Generating Company #2 (TGKB)-エネルギー分野:企業M&A・提携分析
    Summary Territorial Generating Company #2 (TGC-2) is a power generating company. The company produces and transmits electricity, as well as heat, such as steam and hot water. TGC-2 through its subsidiaries offers its products and services to customers located in Arkhangelsk, Vologda, Kostroma, Novgo …
  • Volkswagen Financial Services AG:戦略・SWOT・企業財務分析
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • National Comprehensive Cancer Network:製薬・医療:M&Aディール及び事業提携情報
    Summary National Comprehensive Cancer Network (NCCN) is a not-for-profit cancer center that offers patient care, research, and education services. The center offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and produc …
  • Leap Therapeutics Inc (LPTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • Indena SpA:企業の戦略的SWOT分析
    Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • Universal Music Group Inc:企業の戦略的SWOT分析
    Universal Music Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • DSV AS (DSV):企業の財務・戦略的SWOT分析
    DSV AS (DSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Tufts Medical Center:医療機器:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Terumo Corp (4543):製薬・医療:M&Aディール及び事業提携情報
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • ServiceNow Inc (NOW):企業の財務・戦略的SWOT分析
    ServiceNow Inc (NOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Australia and New Zealand Banking Group Ltd:企業のM&A・事業提携・投資動向
    Australia and New Zealand Banking Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Australia and New Zealand Banking Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Brain Resource Ltd (BRC):企業の財務・戦略的SWOT分析
    Summary Brain Resource Ltd (BRL) is a healthcare service provider that offers therapies. The company carries out research and development of brain products. Its products comprise iSPOT, Total Brain and MyBrainSolutions. BRL’s MyBrainSolutions is a brain health solution to know and train brain for pe …
  • Richelieu Hardware Ltd:企業の戦略・SWOT・財務情報
    Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report Summary Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oracle Financial Services Software Limited (OFSS):企業の財務・戦略的SWOT分析
    Oracle Financial Services Software Limited (OFSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Oracle Corporation (ORCL):企業の財務・戦略的SWOT分析
    Oracle Corporation (ORCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆